Contact
searchSearch
HMP Global

ACTRIMS Meeting Newsroom

Conference Coverage
Study Links MS-Related Fatigue to Disability Status and Lower Quality of Life
03/13/2025
Grace Taylor, MS, MA
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is...
03/13/2025
First Report Managed Care
Conference Coverage
Study Examines the Effects of MS Treatment on Mobility and Emergency Care
03/13/2025
Juliet Gallagher
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study...
03/13/2025
First Report Managed Care
Conference Coverage
Ozanimod Shows Promise in Preserving Brain Volume in Patients With Early Relapsing MS
03/04/2025
Hannah Musick
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in...
03/04/2025
First Report Managed Care
Conference Coverage
Immunomodulatory Effects of Modified Atkins Diet in Patients With Multiple Sclerosis
03/04/2025
Hannah Musick
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a...
03/04/2025
First Report Managed Care
Conference Coverage
MSDA Test Helps Guide Multiple Sclerosis Treatment Decisions, Study Finds
02/28/2025
Grace Taylor, MS, MA
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test...
02/28/2025
First Report Managed Care
Conference Coverage
Study Finds No Treatment Disparities in MS Care Between Medicaid and Private Insurance
02/28/2025
Grace Taylor, MS, MA
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025...
02/28/2025
First Report Managed Care
Conference Coverage
The Clinical and Economic Burden of Primary Progressive Multiple Sclerosis
02/27/2025
Grace Taylor, MS, MA
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the...
02/27/2025
First Report Managed Care
Conference Coverage
Leveraging AI for Multiple Sclerosis Diagnosis
02/27/2025
Grace Taylor, MS, MA
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s...
02/27/2025
First Report Managed Care

Conference Coverage
Study Links MS-Related Fatigue to Disability Status and Lower Quality of Life
03/13/2025
Grace Taylor, MS, MA
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is...
03/13/2025
First Report Managed Care
Conference Coverage
Study Examines the Effects of MS Treatment on Mobility and Emergency Care
03/13/2025
Juliet Gallagher
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study...
03/13/2025
First Report Managed Care
Conference Coverage
Ozanimod Shows Promise in Preserving Brain Volume in Patients With Early Relapsing MS
03/04/2025
Hannah Musick
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in...
03/04/2025
First Report Managed Care
Conference Coverage
Immunomodulatory Effects of Modified Atkins Diet in Patients With Multiple Sclerosis
03/04/2025
Hannah Musick
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a...
03/04/2025
First Report Managed Care
Conference Coverage
MSDA Test Helps Guide Multiple Sclerosis Treatment Decisions, Study Finds
02/28/2025
Grace Taylor, MS, MA
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test...
02/28/2025
First Report Managed Care
Conference Coverage
Study Finds No Treatment Disparities in MS Care Between Medicaid and Private Insurance
02/28/2025
Grace Taylor, MS, MA
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025...
02/28/2025
First Report Managed Care
Conference Coverage
The Clinical and Economic Burden of Primary Progressive Multiple Sclerosis
02/27/2025
Grace Taylor, MS, MA
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the...
02/27/2025
First Report Managed Care
Conference Coverage
Leveraging AI for Multiple Sclerosis Diagnosis
02/27/2025
Grace Taylor, MS, MA
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s...
02/27/2025
First Report Managed Care
Usmani Headshot
Conference Coverage
Rethinking the Risk: Evolving Strategies for High-Risk Smoldering Myeloma at SOHO 2025
09/08/2025
Saad Z. Usmani, MD, FACP
Dr Saad Usmani, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, explores the evolving debate on early intervention for high-risk smoldering multiple myeloma, highlighting pivotal trial data and its potential to reshape...
Dr Saad Usmani, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, explores the evolving debate on early intervention for high-risk smoldering multiple myeloma, highlighting pivotal trial data and its potential to reshape...
Dr Saad Usmani, chief of the...
09/08/2025
First Report Managed Care
Martin
Conference Coverage
What’s Next in Multiple Myeloma: Smoldering, High-Risk, and Frontline Therapy
09/03/2025
Thomas G. Martin, III, MD
Dr Thomas Martin previews his SOHO 2025 session and explores the pressing next questions in multiple myeloma, including when to treat smoldering disease, how to better define and manage high-risk patients, and how innovations like bispecifics...
Dr Thomas Martin previews his SOHO 2025 session and explores the pressing next questions in multiple myeloma, including when to treat smoldering disease, how to better define and manage high-risk patients, and how innovations like bispecifics...
Dr Thomas Martin previews his...
09/03/2025
First Report Managed Care
Raje Headshot
Conference Coverage
CAR T-Cell Therapy in Myeloma: A New Era of Early Intervention
09/02/2025
Noopur S. Raje, MD
At SOHO 2025, Dr Noopur Raje will present a cutting-edge overview of CAR T-cell therapy in multiple myeloma, highlighting long-term efficacy data, novel targets like GPRC5D, emerging dual-targeting and in vivo CAR strategies, and the evolving...
At SOHO 2025, Dr Noopur Raje will present a cutting-edge overview of CAR T-cell therapy in multiple myeloma, highlighting long-term efficacy data, novel targets like GPRC5D, emerging dual-targeting and in vivo CAR strategies, and the evolving...
At SOHO 2025, Dr Noopur Raje...
09/02/2025
First Report Managed Care
Hilger Headshot
Conference Coverage
Smarter Data, Simpler Tools: A New Path for Specialty Pharmacy Optimization
06/26/2025
Chris Hilger
An expert shares a pragmatic approach to tech adoption in infusion centers—starting with simple, high-impact data tools like Power Query that deliver return on investment without the overhead of complex artificial intelligence (AI) systems.
An expert shares a pragmatic approach to tech adoption in infusion centers—starting with simple, high-impact data tools like Power Query that deliver return on investment without the overhead of complex artificial intelligence (AI) systems.
An expert shares a pragmatic...
06/26/2025
First Report Managed Care
Noonan Headshot
Conference Coverage
Evolving Patient Assistance: A Holistic Approach to Access and Engagement
06/26/2025
Learn how a groundbreaking, patient-directed grant structure is improving access and autonomy for individuals with diverse health care needs.
Learn how a groundbreaking, patient-directed grant structure is improving access and autonomy for individuals with diverse health care needs.
Learn how a groundbreaking,...
06/26/2025
First Report Managed Care
McIntyre
Conference Coverage
Staffing and Skill Building for Biologic Therapy in Alternate Sites of Care
06/25/2025
Pamela McIntyre, MSN, RN
As oncology care shifts toward community-based settings, this interview explores how ambulatory infusion centers can prepare clinically and operationally to safely deliver biologic therapies for cancer patients.
As oncology care shifts toward community-based settings, this interview explores how ambulatory infusion centers can prepare clinically and operationally to safely deliver biologic therapies for cancer patients.
As oncology care shifts toward...
06/25/2025
First Report Managed Care
Shackleton
Conference Coverage
The Advocacy Frontier: Navigating PBM Reform, Step Therapy, and More
06/25/2025
Explore how state policies on copay accumulators, PBMs, and step therapy are shaping the future of infusion care—and what you can do about it.
Explore how state policies on copay accumulators, PBMs, and step therapy are shaping the future of infusion care—and what you can do about it.
Explore how state policies on...
06/25/2025
First Report Managed Care
Conference Coverage
Real-World Data May Show Lower Relapse Rates With Ofatumumab Compared to Ocrelizumab in MS Patients
06/03/2025
Hannah Musick
Real-world data show ofatumumab significantly reduces relapse rates compared to ocrelizumab in patients with relapsing multiple sclerosis, including those who are treatment-naïve.
Real-world data show ofatumumab significantly reduces relapse rates compared to ocrelizumab in patients with relapsing multiple sclerosis, including those who are treatment-naïve.
Real-world data show ofatumumab...
06/03/2025
First Report Managed Care
Conference Coverage
Exploring Patient Portal Messaging in MS Care: Value, Utilization, and Burnout Implications
06/03/2025
Juliet Gallagher
As patient portals become increasingly central to chronic disease management, new research presented at CMSC 2025 offers insights into how people living with multiple sclerosis (MS) use these tools—and how their adoption may intersect with...
As patient portals become increasingly central to chronic disease management, new research presented at CMSC 2025 offers insights into how people living with multiple sclerosis (MS) use these tools—and how their adoption may intersect with...
As patient portals become...
06/03/2025
First Report Managed Care
Conference Coverage
11-Year Data Support Sustained Efficacy and Safety of Ocrelizumab in MS
06/02/2025
Juliet Gallagher
At CMSC 2025, researchers presented 11-year follow-up data confirming the long-term efficacy and safety of ocrelizumab (OCR) in people with multiple sclerosis (pwMS), including both relapsing (pwRMS) and primary progressive (pwPPMS) forms of...
At CMSC 2025, researchers presented 11-year follow-up data confirming the long-term efficacy and safety of ocrelizumab (OCR) in people with multiple sclerosis (pwMS), including both relapsing (pwRMS) and primary progressive (pwPPMS) forms of...
At CMSC 2025, researchers...
06/02/2025
First Report Managed Care

What's New?

Conference Coverage
Study Links MS-Related Fatigue to Disability Status and Lower Quality of Life
03/13/2025
Grace Taylor, MS, MA
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is...
03/13/2025
First Report Managed Care
Conference Coverage
Study Examines the Effects of MS Treatment on Mobility and Emergency Care
03/13/2025
Juliet Gallagher
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study...
03/13/2025
First Report Managed Care
Conference Coverage
Ozanimod Shows Promise in Preserving Brain Volume in Patients With Early Relapsing MS
03/04/2025
Hannah Musick
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in...
03/04/2025
First Report Managed Care
Conference Coverage
Immunomodulatory Effects of Modified Atkins Diet in Patients With Multiple Sclerosis
03/04/2025
Hannah Musick
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a...
03/04/2025
First Report Managed Care
Conference Coverage
MSDA Test Helps Guide Multiple Sclerosis Treatment Decisions, Study Finds
02/28/2025
Grace Taylor, MS, MA
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test...
02/28/2025
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use